CORRECTION article

Front. Oncol., 24 October 2023

Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1280727

Corrigendum: C-reactive protein is an indicator of the immunosuppressive microenvironment fostered by myeloid cells in hepatocellular carcinoma

  • 1. Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China

  • 2. Ministry Of Education (MOE) Key Laboratory of Gene Function and Regulation, School of Life Science, Sun Yat-sen University, Guangzhou, China

Error in Figure/Table

In the published article, there was an error in Figure 4 as published. The figure showed that the abundance of immune cell subsets in tumor tissue of patients with high or low serum CRP levels. However, during the editing process of the figure, we inadvertently entered the wrong values of cell subset-Mo, NK, DC, CD4, CD8 Tcm and Treg, which resulted in the error of Figures 4D–I. The corrected Figure 4 and its caption appear below.

Figure 4

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

CRP, HCC, immune microenviroment, tumor associated macrophage, tumor associated neutrophil

Citation

Wang Y, Li Z, Huang Z, Yu X, Zheng L and Xu J (2023) Corrigendum: C-reactive protein is an indicator of the immunosuppressive microenvironment fostered by myeloid cells in hepatocellular carcinoma. Front. Oncol. 13:1280727. doi: 10.3389/fonc.2023.1280727

Received

21 August 2023

Accepted

28 August 2023

Published

24 October 2023

Volume

13 - 2023

Edited and reviewed by

Rongxin Zhang, Guangdong Pharmaceutical University, China

Updates

Copyright

*Correspondence: Jing Xu,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics